We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

The US Biosimilars Patent Litigation Outlook For 2019

Law360 (January 18, 2019, 3:49 PM EST) -- In 2010, President Barack Obama signed the Biologics Price Competition and Innovation Act into law as part of the Affordable Care Act, establishing an abbreviated regulatory pathway for biosimilar approvals and...
To view the full article, register now.